Ontology highlight
ABSTRACT: Background
The therapeutic benefits of mesenchymal stromal cells (MSCs) include treatment of chronic inflammation. However, given the short-lived engraftment of these cells in vivo, their therapeutic efficacy remains mysterious. Transient induction of cellular senescence contributes to activation of immune cells, which promotes clearance of damaged cells during tissue remodelling. This may occur in tissue-resident mesenchymal progenitor cells during regeneration. Elucidation of the role of senescence in tissue-resident mesenchymal progenitor cells during regeneration would provide insight into the profile of therapeutic MSCs for treatment of chronic inflammatory disease.Methods
We evaluated multipotent mesenchymal progenitor cells, termed fibro/adipogenic progenitors (FAPs)
SUBMITTER: Chikenji TS
PROVIDER: S-EPMC6604166 | biostudies-literature | 2019 Jun
REPOSITORIES: biostudies-literature